Dr. Martens Statistics
Total Valuation
Dr. Martens has a market cap or net worth of 1.07 billion. The enterprise value is 1.41 billion.
| Market Cap | 1.07B |
| Enterprise Value | 1.41B |
Important Dates
The last earnings date was Thursday, June 5, 2025.
| Earnings Date | Jun 5, 2025 |
| Ex-Dividend Date | Mar 7, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -1.17% |
| Shares Change (QoQ) | +6.06% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 500.07M |
Valuation Ratios
The trailing PE ratio is 183.66 and the forward PE ratio is 18.71.
| PE Ratio | 183.66 |
| Forward PE | 18.71 |
| PS Ratio | 1.05 |
| PB Ratio | 2.26 |
| P/TBV Ratio | 8.94 |
| P/FCF Ratio | 4.40 |
| P/OCF Ratio | 4.21 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.18, with an EV/FCF ratio of 5.78.
| EV / Earnings | 241.29 |
| EV / Sales | 1.32 |
| EV / EBITDA | 8.18 |
| EV / EBIT | 17.12 |
| EV / FCF | 5.78 |
Financial Position
The company has a current ratio of 2.59, with a Debt / Equity ratio of 1.10.
| Current Ratio | 2.59 |
| Quick Ratio | 1.37 |
| Debt / Equity | 1.10 |
| Debt / EBITDA | 3.18 |
| Debt / FCF | 2.15 |
| Interest Coverage | 2.01 |
Financial Efficiency
Return on equity (ROE) is 1.23% and return on invested capital (ROIC) is 4.70%.
| Return on Equity (ROE) | 1.23% |
| Return on Assets (ROA) | 4.12% |
| Return on Invested Capital (ROIC) | 4.70% |
| Return on Capital Employed (ROCE) | 8.30% |
| Revenue Per Employee | 387,675 |
| Profits Per Employee | 2,215 |
| Employee Count | 2,630 |
| Asset Turnover | 0.86 |
| Inventory Turnover | 1.25 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -29.43% in the last 52 weeks. The beta is 0.15, so Dr. Martens's price volatility has been lower than the market average.
| Beta (5Y) | 0.15 |
| 52-Week Price Change | -29.43% |
| 50-Day Moving Average | 1.67 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 51.08 |
| Average Volume (20 Days) | 946 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Dr. Martens had revenue of 1.02 billion and earned 5.83 million in profits. Earnings per share was 0.01.
| Revenue | 1.02B |
| Gross Profit | 662.42M |
| Operating Income | 78.58M |
| Pretax Income | 11.39M |
| Net Income | 5.83M |
| EBITDA | 98.00M |
| EBIT | 78.58M |
| Earnings Per Share (EPS) | 0.01 |
Balance Sheet
The company has 201.82 million in cash and 523.13 million in debt, giving a net cash position of -321.31 million.
| Cash & Cash Equivalents | 201.82M |
| Total Debt | 523.13M |
| Net Cash | -321.31M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 474.32M |
| Book Value Per Share | 0.49 |
| Working Capital | 326.61M |
Cash Flow
In the last 12 months, operating cash flow was 254.12 million and capital expenditures -10.87 million, giving a free cash flow of 243.25 million.
| Operating Cash Flow | 254.12M |
| Capital Expenditures | -10.87M |
| Free Cash Flow | 243.25M |
| FCF Per Share | n/a |
Margins
Gross margin is 64.97%, with operating and profit margins of 7.71% and 0.57%.
| Gross Margin | 64.97% |
| Operating Margin | 7.71% |
| Pretax Margin | 1.12% |
| Profit Margin | 0.57% |
| EBITDA Margin | 9.61% |
| EBIT Margin | 7.71% |
| FCF Margin | 23.86% |
Dividends & Yields
This stock pays an annual dividend of 0.04, which amounts to a dividend yield of 2.58%.
| Dividend Per Share | 0.04 |
| Dividend Yield | 2.58% |
| Dividend Growth (YoY) | -68.50% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 211.11% |
| Buyback Yield | 1.17% |
| Shareholder Yield | 3.75% |
| Earnings Yield | 0.54% |
| FCF Yield | 22.74% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Dr. Martens has an Altman Z-Score of 4.97.
| Altman Z-Score | 4.97 |
| Piotroski F-Score | n/a |